Headlines
-
Pay rates “embarrassing”
Monday | May 6 2019PHARMACISTS' salaries are embarrassingly low, according to one pharmacy owner who responded to the recent Pharmacy Daily Salary Survey (PD 05 Apr).
-
TWCM Pharmacist of the Year
Monday | May 6 2019TERRYWHITE Chemmart has named Renee Wynne as the group's Pharmacist of the Year for 2019.
-
No unilateral CPA changes
Friday | May 3 2019A FEDERAL Government led by either of the two major parties will not impose unilateral changes on community pharmacists outside of the Community Pharmacy Agreement.
-
Queensland scripts slammed
Friday | May 3 2019QUEENSLAND'S trial of pharmacist prescribing is a "fundamental corruption of a safety check that has stood the test of time", according to the Australian Medical Association (AMA).
-
SHPA fears $44m PBS cuts
Friday | May 3 2019PROMISES of increased funding for new medicines will mean little if $44 million cuts to hospital pharmacy are implemented, the Society of Hospital Pharmacists of Australia (SHPA) warns.
-
Just one Rx option: Guild
Thursday | May 2 2019THE Pharmacy Guild of Australia has rejected "insulting" responses from doctors' groups in relation to proposals for pharmacist prescribing (PD 17 Apr), saying their "negativity does them no credit" and could ultimately serve to limit patient access to healthcare.
-
TWC Masterclass gives pharmacists a boost
Thursday | May 2 2019TERRY White Chemmart pharmacists have given their clinical skills a shot in the arm by taking part in the group's annual masterclass.
-
Guild “wrong” on codeine
Thursday | May 2 2019FALLING codeine sales is evidence that the Therapeutic Goods Administration (TGA) was right to upschedule the medications to prescription-only, the Australian Medical Association claims.
-
Rural health not political
Wednesday | May 1 2019RURAL Australian's healthcare should not be compromised by poor mobile connectivity, the National Rural Health Alliance (NRHA) believes.
-
Seqirus warns of pandemic
Wednesday | May 1 2019REFERENCING the potent H7N9 strain of influenza, CSL vaccine offshoot Seqirus has alerted investors to the possibility of another influenza pandemic.